
Madrigal Pharmaceuticals, Inc.
MDGLNasdaqCIK 1157601HealthcareFiscal year ends Dec 31
Reports and events: 322 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2023-11-2117:24 ET | SC 13D/A | Ownership report, active investor, amended | 0001104659-23-120429 |
| 2023-11-0608:31 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-23-270884 |
| 2023-11-0606:10 ET | 10-Q | Quarterly reportPeriod 2023-09-30 | 0001193125-23-270803 |
| 2023-10-0516:36 ET | SC 13D/A | Ownership report, active investor, amended | 0001104659-23-107213 |
| 2023-10-0217:15 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001193125-23-249192 |
| 2023-09-2516:02 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001193125-23-241315 |
| 2023-09-1416:31 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001193125-23-235340 |
| 2023-09-1316:30 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001193125-23-234395 |
| 2023-09-1316:25 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-23-234385 |
| 2023-08-0817:16 ET | SC 13D/A | Ownership report, active investor, amended | 0001104659-23-088894 |
| 2023-08-0808:00 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-23-205600 |
| 2023-08-0806:50 ET | 10-Q | Quarterly reportPeriod 2023-06-30 | 0001193125-23-205535 |
| 2023-07-1708:00 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-23-187698 |
| 2023-06-3008:00 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-23-179440 |
| 2023-06-2019:18 ET | SC 13D | Ownership report, active investor | 0001104659-23-072412 |
| 2023-06-2019:00 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001193125-23-169190 |
| 2023-06-2018:54 ET | 8-K | 5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001193125-23-169187 |
| 2023-05-0908:16 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001193125-23-138953 |
| 2023-05-0908:00 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-23-138931 |
| 2023-05-0906:51 ET | 10-Q | Quarterly reportPeriod 2023-03-31 | 0001193125-23-138863 |
| 2023-05-0109:11 ET | DEF 14A | Proxy statement | 0001193125-23-128960 |
| 2023-03-0316:17 ET | 10-K/A | Annual report, amendedPeriod 2022-12-31 | 0001193125-23-060052 |
| 2023-02-2308:02 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-23-045671 |
| 2023-02-2306:32 ET | 10-K | Annual reportPeriod 2022-12-31 | 0001193125-23-045575 |
| 2023-02-0917:01 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001193125-23-030281 |
| 2023-01-1017:00 ET | 8-K | 8.01 Other events | 0001193125-23-005674 |
| 2022-12-2307:00 ET | 8-K | 1.01 Entry into a material agreement; 5.03 Amendment to articles or bylaws; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-22-311537 |
| 2022-12-1908:42 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events | 0001193125-22-307935 |
| 2022-11-0308:56 ET | 10-Q | Quarterly reportPeriod 2022-09-30 | 0001193125-22-276468 |
| 2022-11-0308:01 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-22-276424 |
| 2022-08-0406:33 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-22-211760 |
| 2022-08-0406:31 ET | 10-Q | Quarterly reportPeriod 2022-06-30 | 0001193125-22-211757 |
| 2022-06-1712:33 ET | 8-K | 5.07 Shareholder vote results | 0001193125-22-176256 |
| 2022-05-0912:55 ET | 10-Q | Quarterly reportPeriod 2022-03-31 | 0001193125-22-144674 |
| 2022-05-0910:22 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity | 0001193125-22-144506 |
| 2022-05-0906:33 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-22-144230 |
| 2022-05-0211:40 ET | DEF 14A | Proxy statementPeriod 2022-06-15 | 0001193125-22-136035 |
| 2022-02-2413:39 ET | 10-K | Annual reportPeriod 2021-12-31 | 0001193125-22-051569 |
| 2022-02-2408:01 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-22-051135 |
| 2021-12-0716:30 ET | SC 13D/A | Ownership report, active investor, amended | 0001193125-21-350295 |
| 2021-11-0408:30 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-21-319413 |
| 2021-11-0406:07 ET | 10-Q | Quarterly reportPeriod 2021-09-30 | 0001193125-21-319159 |
| 2021-08-0508:31 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-21-237087 |
| 2021-08-0506:51 ET | 10-Q | Quarterly reportPeriod 2021-06-30 | 0001193125-21-236933 |
| 2021-06-2110:56 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results | 0001193125-21-194456 |
| 2021-06-0108:01 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001193125-21-177871 |
| 2021-05-1808:30 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-21-164670 |
| 2021-05-0608:31 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-21-152675 |
| 2021-05-0606:10 ET | 10-Q | Quarterly reportPeriod 2021-03-31 | 0001193125-21-152386 |
| 2021-04-3015:59 ET | DEF 14A | Proxy statementPeriod 2021-06-17 | 0001193125-21-144922 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Nov 6, 2026, 18:49 ET. Listed shows no prices and gives no investment advice.